Bibliografia UJ CM




Zapytanie: ALLENDORF DANIEL J
Liczba odnalezionych rekordów: 10



Przejście do opcji zmiany formatu | Wyświetl/ukryj etykiety | Wersja do druku | | | Nowe wyszukiwanie
1/10
Jarek Baran, Daniel J. Allendorf, Feng Hong, Gordon D. Ross.
Oral β-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice.
Folia Histochemica et Cytobiologica
2007 : Vol. 45, nr 2, s. 107-114, il., bibliogr. 48 poz., abstr.
p-ISSN: 0239-8508

AP
ORG
AIF
IF: 0.886
Adres url:
2/10
Daniel J. Allendorf, Jun Yan, Gordon D. Ross, Richard D. Hansen, Jarek T. Baran, Krishnaprasad Subbarao, Li Wang, Bodduluri Haribabu.
C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan.
J. Immunol.
2005 : Vol. 174, nr 11, s. 7050-7056, il., bibliogr. 50 poz.
AZ
ORG
AIF
IF: 6.387
3/10
J[arosław] T. Baran, D[aniel] J. Allendorf, F[eng] Hong, J. Yan, R[ichard] D. Hansen, G[ary] R. Ostroff, G[ordon] D. Ross.
Orally administered beta-glucan potentiates tumoricidal effects of monoclonal antibodies by recruiting in a macrophage-dependent manner granulocytes as killer cells in mouse tumor models.
Central European Journal of Immunology
2005 : Vol. 30 suppl. 1, s. 3, abstr. 8.
12th Congress of Polish Society of Clinical and Experimental Immunology : abstracts, Lublin, Poland, 19th-22nd May, 2005.
SZP
AWZ
4/10
Magdalena Kucia, Kacper Jankowski, Ryan Reca, Marcin Wysoczynski, Laura Bandura, Daniel J. Allendorf, Jin Zhang, Janina Ratajczak, Mariusz Z. Ratajczak.
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.
J. Mol. Histol.
2004 : Vol. 35, nr 3, s. 233-245, il., bibliogr., summ.
do roku 3003 Histochem. J., ISSN 1567-2379.
p-ISSN: 0018-2214

AZ
POG
AIF
IF: 0.928
5/10
Feng Hong, Jun Yan, Jarek T. Baran, Daniel J. Allendorf, Richard D. Hansen, Gary R. Ostroff, Pei Xiang Xing, Nai-Kong V. Cheung, Gordon D. Ross.
Mechanism by Which Orally Administered β-1,3-Glucans Enhance the Tumoricidal Activity of Antitumor Monoclonal Antibodies in Murine Tumor Models.
J. Immunol.
2004 : Vol. 173, nr 2, s. 797-806, il., bibliogr.
AZ
ORG
AIF
IF: 6.486
Adres url:
6/10
M[ariusz] Z. Ratajczak, R[yan] Reca, M[arcin] Wysoczynski, M[agda] Kucia, J[arosław] T. Baran, D[aniel] J. Allendorf, J[anina] Ratajczak, G[ordon] D. Ross.
Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells.
Leukemia
2004 : Vol. 18, nr 9, s. 1482-1490, il., bibliogr. 60 poz.
AZ
ORG
AIF
IF: 5.810
Adres url:
7/10
Feng Hong, Richard D. Hansen, Jun Yan, Daniel J. Allendorf, Jarek T. Baran, Gary R. Ostroff, Gordon D. Ross.
β-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
Cancer Research
2003 : Vol. 63, nr 24, s. 9023-9031, il. bibliogr. 45 poz.,
AZ
ORG
AIF
IF: 8.649
Adres url:
8/10
Daniel J. Allendorf, Jarek T. Baran, Richard D. Hansen, Feng Hong, Jose Marroquin, Jun Yan, Dick Walsh, Gordon Ross.
Macrophages shuttle orally administered β-glucan to potentiate the CR3-dependent tumoricidal effects of monoclonal antibodies in mouse tumor models.
W: 90th Anniversary Annual Meeting of the American Association of Immunologists : Immunology 2003, Denver, Colorado, May 6-10, 2003 : abstracts
s. C128 : abstr. 73.26.
SZZ
AWZ
9/10
Daniel J. Allendorf, Jarek T. Baran, Richard D. Hansen, Krishnaprasad Subbarao, Dick Walsh, Feng Hong, Jose Marroquin, Jun Yan, John D. Lambris, Bodduluri Haribabu, Gordon D. Ross.
Orally administered β-glucan functions via anti-tumor mAbs and the complement system to recruit CR3+ neutrophils and macrophages that produce tumor regression and tumor-free survival.
Mol. Immunol.
2003 : Vol. 40, s. 195-196, abstr. 51
9th European Meeting on Complement in Human Disease, Trieste-Italy, September 6-9, 2003.
SZZ
SIF
10/10
Gordon D. Ross, Richard D. Hansen, Daniel J. Allendorf, Jarek T. Baran, Jun Yan, Krishnaprasad Subbarao, Bodduluri Haribabu, John D. Lambris.
Tumor regression mediated by β-glucans against iC3b-opsonized tumors requires CR3+ neutrophils recruited via C5a and leukotriene B4 (LTB4).
W: 90th Anniversary Annual Meeting of the American Association of Immunologists : Immunology 2003, Denver, Colorado, May 6-10, 2003 : abstracts
s. C128 : abstr. 73.27.
SZZ
AWZ
  Wyświetl ponownie stosując format:
Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ